Precision medicine was meant to see the end of ‘maximum tolerated dose’ as the standard for introducing new drugs. It hasn’t happened, and many patients continue to suffer unnecessary toxicity from overtreatment, with health services [more]
Molecular imaging specialists are ready to break out of their research huddles and take their place at the heart of clinical decision making. But can they convince clinicians to welcome them in? Anna Wagstaff investigates. [more]
A new model of active surveillance (AS) for patients with low-risk prostate cancer proved to be effective in helping clinicians to appropriately select and follow patients preventing the risk of overtreatment, according to the results [more]
A new conference looks at the social as well as individual implications of how we use diagnostic tests that cannot accurately pick out real from apparent threats. Improving the way we spot, report and explore [more]
Ending the overtreatment of women with DCIS will require enough women to have the courage and insight to demand something better. Tiffany OCallaghan won a Best Cancer Reporter Award for opening up the debate with [more]
This editorial argues that handling the transition from active to palliative care is indeed a weak point in oncology, and if the cancer community fails to address it, we will leave it open to the [more]
According to Kaasa, head of the Cancer Clinic at Trondheim University Hospital, patients are falling through gaps in care provision because palliative care is seen as an add-on rather than integral to care plans. The [more]